Tuesday, Jan 27, 2026 · SEC filings

What the smart money revealed on Jan 27

Real insider buys28insiders · $10M
Real insider sales41insiders · $77M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

461 insider filings came in. We hid 18 planned (10b5-1) sellers and 353 people whose filings were routine, like grants and tax withholding.

trending_up

Mirum Pharmaceuticals (MIRM) Director Patrick Heron bought $9M

131,425 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 6 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 4 of 6 beat Traded Jan 23
$9M
trending_up

Intel (INTC) EVP David Zinsner bought $250K

5,882 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 26
$250K
trending_up

TCG Strategic Income Fund (TCGSX) Director Leonard Tannenbaum bought $200K

19,841 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 11 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 2 of 11 beat Traded Jan 26
$200K
trending_up

EquipmentShare.com (EQPT) CFO & Chief Accounting Officer David Marquardt bought $105K

4,285 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 26
$105K
trending_down

AutoZone (AZO) Sr. Vice President Richard Smith sold $21.9M

Not marked as a planned 10b5-1 sale. Sold 69% of the shares they held directly. Still holds 2,627 shares.

Real sale Form 4 Sold 69% of stake Traded Jan 23
$21.9M
trending_down

Goldman Sachs Group (GS) Chief Legal Officer Kathryn Ruemmler sold $8.89M

Not marked as a planned 10b5-1 sale. Sold 34% of the shares they held directly. Still holds 18,533 shares.

Real sale Form 4 Sold 34% of stake Traded Jan 23
$8.89M
trending_down

Bitgo (BTGO) COO Jody Mettler sold $418K

Not marked as a planned 10b5-1 sale. Sold 50% of the shares they held directly. Still holds 25,000 shares.

Real sale Form 4 Sold 50% of stake Traded Jan 23
$418K
Show 24 more real buys
TCBI Texas Capital Bancshares · Director Laura Whitley · Traded Jan 23–26
$97.5K
STEX Streamex · Director Morgan Lekstrom · Traded Jan 26–27
$93.1K
CRSP Crispr Therapeutics AG · Chief Medical Officer Naimish Patel · Traded Apr 3
$49.7K
TCBI Texas Capital Bancshares · Director Robert Stallings · Traded Jan 23
$41.8K
BFST Business First Bancshares · Director Rick Day · Traded Jan 27
$41.3K
PMT PennyMac Mortgage Investment Trust · Director Catherine Lynch · Traded Jan 23
$19.2K
ZIVO Zivo Bioscience · Director Christopher Maggiore · Traded Jan 14
$15K
ZIVO Zivo Bioscience · Director Laith Yaldoo · Traded Jan 14
$15K
JHS John Hancock Income Securities Trust · Director Kenneth Phelan · Traded Jan 26–27
$10.1K
HEQ John Hancock Diversified Income Fund · Director Kenneth Phelan · Traded Jan 27
$10K
JHI John Hancock Investors Trust · Director Kenneth Phelan · Traded Jan 27
$10K
BTO John Hancock Financial Opportunities Fund · Director Kenneth Phelan · Traded Jan 26
$10K
HPI John Hancock Preferred Income Fund · Director Kenneth Phelan · Traded Jan 26
$10K
HPF John Hancock Preferred Income Fund II · Director Kenneth Phelan · Traded Jan 26
$10K
PDT John Hancock Premium Dividend Fund · Director Kenneth Phelan · Traded Jan 26
$10K
HPS John Hancock Preferred Income Fund III · Director Kenneth Phelan · Traded Jan 26
$10K
HTD John Hancock Tax-Advantaged Dividend Income Fund · Director Kenneth Phelan · Traded Jan 26
$10K
IRIX Iridex · CFO Romeo Dizon · Traded Jan 27
$5.01K
DLPN Dolphin Entertainment · CEO William O'Dowd · Traded Jan 26
$4.89K
RCG RENN Fund · President/Co-Portfolio Manager Murray Stahl · Traded Jan 26
$3.06K
FAST Fastenal · Senior EVP-Sales Charles Miller · Traded Apr 7–14
$1.57K
CVS CVS Health · EVP and President Steven Nelson · Traded Jan 23
$1.29K
Fundrise Real Estate Interval Fund · Treasurer Alison Staloch · Traded Jan 26
$459
Fundrise Income Real Estate Fund · Treasurer Alison Staloch · Traded Jan 26
$41
Show 38 more real sales
SYM Symbotic · CTO James Kuffner · Traded Jan 26
$4.62M
GS Goldman Sachs Group · Chief Accounting Officer Sheara Fredman · Traded Jan 23
$4.49M
BTGO Bitgo · Chief Revenue Officer Chen Fang · Traded Jan 23
$4.18M
PTGX Protagonist Therapeutics · President and CEO Patel Dinesh V Ph D · Traded Jan 23–27
$4.06M
PTGX Protagonist Therapeutics · CFO Asif Ali · Traded Jan 27
$3.84M
NTRS Northern Trust · COO Peter Cherecwich · Traded Jan 26
$3.74M
SLB SLB Limited · EVP & CFO Stephane Biguet · Traded Jan 26
$3.03M
SLB SLB Limited · EVP Abdellah Merad · Traded Jan 26
$2.98M
BTGO Bitgo · Chief Compliance Officer Jeff Horowitz · Traded Jan 23
$1.94M
PTGX Protagonist Therapeutics · Chief Medical Officer Arturo Molina · Traded Jan 23–27
$1.91M
GS Goldman Sachs Group · Global Treasurer Carey Halio · Traded Jan 23
$1.62M
SLB SLB Limited · Chief Legal Officer & Sec Dianne Ralston · Traded Jan 26
$922K
TSHA Taysha Gene Therapies · CEO Sean Nolan · Traded Jan 23–26
$840K
BTGO Bitgo · CFO Edward Reginelli · Traded Jan 23
$753K
FAST Fastenal · Director Scott Satterlee · Traded Jan 23
$705K
SLB SLB Limited · Chief Accounting Officer Howard Guild · Traded Jan 26
$659K
MIRM Mirum Pharmaceuticals · CEO Christopher Peetz · Traded Jan 26
$657K
DRI Darden Restaurants · Director Charles Sonsteby · Traded Jan 23
$641K
TSHA Taysha Gene Therapies · President and Head of R&D Sukumar Nagendran · Traded Jan 23–26
$547K
IRMD Iradimed · CEO Roger Susi · Traded Jan 26
$503K
ADBE Adobe · EVP & CFO Daniel Durn · Traded Jan 27
$485K
TSHA Taysha Gene Therapies · CFO Kamran Alam · Traded Jan 23–26
$485K
SYM Symbotic · Officer Maria Freve · Traded Jan 26
$400K
GSBC Great Southern Bancorp · President/CEO Joseph Turner · Traded Jan 26
$364K
MIRM Mirum Pharmaceuticals · President and COO Peter Radovich · Traded Jan 26
$302K
PSMT PriceSmart · Director Robert Price · Traded Jan 26
$283K
SLB SLB Limited · Director Patrick de La Chevardiere · Traded Jan 26
$201K
TWST Twist Bioscience · President and COO Patrick Finn · Traded Jan 23
$107K
MIRM Mirum Pharmaceuticals · CFO Eric Bjerkholt · Traded Jan 26
$101K
KURA Kura Oncology · Chief Legal Officer Teresa Bair · Traded Jan 27
$94.8K
HAL Halliburton · Director Margaret Banks · Traded Jan 26
$88.9K
MIRM Mirum Pharmaceuticals · SVP Jolanda Howe · Traded Jan 26
$81K
KURA Kura Oncology · Chief Medical Officer Mollie Leoni · Traded Jan 27
$69.2K
KURA Kura Oncology · SVP Thomas Doyle · Traded Jan 27
$60.4K
KURA Kura Oncology · Chief Commercial Officer Brian Powl · Traded Jan 27
$54.3K
KURA Kura Oncology · COO Kathleen Ford · Traded Jan 27
$15.3K
MDBH MDB Capital · CFO Jeremy James · Traded Jan 26–23
$11.6K
KURA Kura Oncology · Chief Scientific Officer Francis Burrows · Traded Jan 27
$11.1K

13F season

Holdings as of Dec 31, 2025 are due Feb 17

320 funds have filed so far. 81 filed for the quarter before.

Biggest real insider buys this week

Open-market buys by officers and directors, filed in the 7 days up to Jan 27.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist